Whole‐exome sequencing in the evaluation of fetal congenital anomalies of the kidney and urinary tract detected by ultrasonography. (15th July 2020)

• Record Type: Journal Article
• Authors: Lei, Ting‐Ying; Fu, Fang; Li, Ru; Yu, Qiu‐Xia; Du, Kun; Zhang, Wen‐Wen; Deng, Qiong; Li, Lu‐Shan; Wang, Dan; Yang, Xin; Zhen, Li; Li, Dong‐Zhi; Liao, Can
• Is Part Of: Prenatal diagnosis. Volume 40:Number 10(2020)
• Page Start: 1290
• Page End: 1299
• Publication Date: 2020-07-15
• Subjects: Prenatal diagnosis -- Periodicals; Fetus -- Diseases -- Diagnosis -- Periodicals; Electronic journals; 618.32075
• DOI: 10.1002/pd.5737
• Languages: English
• ISSNs: 0197-3851

Abstract

Abstract: Objective: We aimed to investigate the value of whole‐exome sequencing (WES) in fetuses with congenital anomalies of the kidney and urinary tract (CAKUT) with or without other structural anomalies but with normal findings upon karyotyping and chromosome microarray analysis (CMA). Methods: Cases with CAKUT with or without other structural anomalies were screened for eligibility. Fetuses with abnormal karyotyping or CMA results were excluded. We performed WES on DNA samples from eligible fetus‐parental trios and identified diagnostic genetic variants based on ultrasonographic features. Results: A total of 163 eligible fetus‐parental trios were successfully analyzed by WES. We found 26 likely pathogenic or pathogenic variants in 18 genes from 20 fetuses, with a total proportion of diagnostic genetic variants of 12.3% (20/163). Genetic variants were significantly more frequently detected in fetuses with multisystem anomalies (27.0%, 10/37), enlarged kidney/echogenic kidney (20%, 4/20), and multicystic dysplastic kidney (11.1%, 4/36). Pregnancy outcome data showed that 88 (94.6%, 88/93) of the surviving cases with negative WES results had a good prognosis in early childhood. Conclusions: Our study is the largest to use WES prenatally for CAKUT and shows that WES can be used diagnostically to define the molecular defects that underlie unexplained CAKUT.